Artificial Blood Market Professional Survey Report 2019

The global Artificial Blood market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

This report focuses on Artificial Blood volume and value at global level, regional level and company level. From a global perspective, this report represents overall Artificial Blood market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Artificial Blood in North America, Europe, China, Japan, Southeast Asia and India.

Download FREE Sample of this Report @

For each manufacturer covered, this report analyzes their Artificial Blood manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:

  • Dextro-Sang Corporation
  • BioPure Corporation
  • Sangart
  • Northfield Laboratories
  • Baxter International
  • Dentritech
  • FluorO2 Therapeutics
  • Nuvox Pharma
  • Alpha Therapeutic Corporation
  • HemoBioTech

Segment by Regions

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

Segment by Type

  • Human Blood
  • Synthetic Blood
  • Animal Blood

Segment by Application

  • Hemoglobin-Based Oxygen Carriers (HBOCs)
  • Perflurocarbon Emulsions (PFCEs)

Get the Complete Report & TOC @

Table of content

Table of Contents

Executive Summary
1 Industry Overview of Artificial Blood
1.1 Definition of Artificial Blood
1.2 Artificial Blood Segment by Type
1.2.1 Global Artificial Blood Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Human Blood
1.2.3 Synthetic Blood
1.2.4 Animal Blood
1.3 Artificial Blood Segment by Applications
1.3.1 Global Artificial Blood Consumption Comparison by Applications (2014-2025)
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Global Artificial Blood Overall Market
1.4.1 Global Artificial Blood Revenue (2014-2025)
1.4.2 Global Artificial Blood Production (2014-2025)
1.4.3 North America Artificial Blood Status and Prospect (2014-2025)
1.4.4 Europe Artificial Blood Status and Prospect (2014-2025)
1.4.5 China Artificial Blood Status and Prospect (2014-2025)
1.4.6 Japan Artificial Blood Status and Prospect (2014-2025)
1.4.7 Southeast Asia Artificial Blood Status and Prospect (2014-2025)
1.4.8 India Artificial Blood Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Artificial Blood
2.3 Manufacturing Process Analysis of Artificial Blood
2.4 Industry Chain Structure of Artificial Blood

3 Development and Manufacturing Plants Analy

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :-